EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a 3’3’‐Cyclic GMP‐AMP Enzyme Linked Immunoassay Reveals Phage Infection Reduces DncV Activity

Kaylee M. Wilburn, Julianna B. Blaylock, Kerry C. Metcalfe, Brian Y. Hsueh, Daniel J. Tew, Christopher M. Waters

Israel Journal of Chemistry · 2023-06 · 63 (5-6)

DOI: 10.1002/ijch.202200084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Israel Journal of Chemistry, online erschienen am 04.01.2023. Verfasst von Kaylee M. Wilburn und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

East Lansing, MI 48824 Cyclic di‐nucleotides (CDNs) are central signaling molecules in organisms spanning the tree of life. In bacteria, CDNs mediate many important physiological functions such as biofilm formation, motility, and virulence. CDNs are also implicated in activation of cellular biological defense systems in both bacteria and eukaryotes. In bacteria, the CDN 3’3’‐cyclic GMP‐AMP (3’3’‐cGAMP) activates a putative phage defense system in Vibrio cholerae and controls central physiological processes in Geobacter sulfurreducens and Bdellovibrio bacteriovorus . Therefore, access to a rapid, accurate 3’3’‐cGAMP quantification assay would enable further studies of this signaling molecule. Here, we describe validation of a novel 3’3’‐cGAMP enzyme linked immunoassay (ELISA) developed by Cayman Chemicals. We demonstrate that the concentrations of 3’3’‐cGAMP determined by this ELISA strongly correlate with those obtained using liquid chromatography‐tandem mass spectrometry (LC‐MS/MS). Furthermore, during these studies we show that the V. cholerae 3’3’‐cGAMP synthase, DncV, when expressed by itself in Escherichia coli , is not activated by phage infection.

Förderung

  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Wilburn, K. M., Blaylock, J. B., Metcalfe, K. C., Hsueh, B. Y., Tew, D. J., & Waters, C. M. (2023). Development of a 3’3’‐Cyclic GMP‐AMP Enzyme Linked Immunoassay Reveals Phage Infection Reduces DncV Activity. Israel Journal of Chemistry, 63(5-6). https://doi.org/10.1002/ijch.202200084

Vancouver

Wilburn KM, Blaylock JB, Metcalfe KC, Hsueh BY, Tew DJ, Waters CM. Development of a 3’3’‐Cyclic GMP‐AMP Enzyme Linked Immunoassay Reveals Phage Infection Reduces DncV Activity. Israel Journal of Chemistry. 2023;63(5-6). doi:10.1002/ijch.202200084

BibTeX
@article{Wilburn2023,
  author = {Wilburn, Kaylee M. and Blaylock, Julianna B. and Metcalfe, Kerry C. and Hsueh, Brian Y. and Tew, Daniel J. and Waters, Christopher M.},
  title = {Development of a 3’3’‐Cyclic GMP‐AMP Enzyme Linked Immunoassay Reveals Phage Infection Reduces DncV Activity},
  journal = {Israel Journal of Chemistry},
  year = {2023},
  volume = {63},
  number = {5-6},
  doi = {10.1002/ijch.202200084}
}
Kostenlos starten →